From infectious diseases to personalised medicine, India enters futuristic healthcare phase: Dr Jitendra Singh

1. At a Glance

Union MoS (I/C) Science & Technology Dr Jitendra Singh asserted India is shifting from an infectious-disease focus to personalised/precision medicine, anchored in genomics, biotech and rare-disease care [S1].
Announcement made while laying foundation stone of SAMARTH Skill Centre and inaugurating the iDEA-NA BRIC-CDFD Technology Incubator at DBT-CDFD, Hyderabad on 9 Jan 2026 [S1].
Connects to GS-II (Health policy) and GS-III (Biotech, S&T) — overlaps with National Policy for Rare Diseases 2021, BIRAC, BioE3 Policy, Genome India Project [S1][S2].

9 Jan 2026 PIB release by Ministry of Science & Technology: Dr Jitendra Singh inaugurated the iDEA-NA BRIC-CDFD Technology Incubator and laid foundation of SAMARTH national skill centre at CDFD Hyderabad [S1].
Statement flagged early detection and affordability as the two biggest challenges in genetic/rare diseases [S1].

CDFD (Centre for DNA Fingerprinting and Diagnostics) — autonomous institute under DBT, located at Nampally, Hyderabad; founded 1995 [S4].
DBT restructured 14 autonomous institutes under a single umbrella BRIC (Biotechnology Research and Innovation Council) to improve coordination and industry linkages [S5].
National Policy for Rare Diseases (NPRD) approved by Union Health Minister Dr Harsh Vardhan on 30 March 2021 — replaced the 2017 draft policy [S2].

Nodal ministry (event): Ministry of Science & Technology → Department of Biotechnology (DBT) [S1].
Implementing institute: BRIC-CDFD, Hyderabad [S1][S4].
NPRD 2021 classifies rare diseases into 3 Groups:
Group 1 — one-time curative treatment.
Group 2 — long-term, relatively low-cost treatment.
Group 3 — definitive treatment exists but very high lifelong cost [S3].
Financial support: up to ₹50 lakh per patient at notified Centres of Excellence under NPRD 2021 [S3].
8 Centres of Excellence (CoEs) + 5 Nidan Kendras for genetic testing/counselling [S3].
SAMARTH — National Skill Development Centre at CDFD for biotech skilling [S1].
iDEA-NA — BRIC-CDFD Technology Incubator for nucleic-acid / diagnostics start-ups [S1].

Scientific / Technological: Shift to precision/personalised medicine built on genomics, DNA fingerprinting and indigenous diagnostic platforms at CDFD [S1][S4].
Economic: Incubator model (iDEA-NA) seeks to crowd-in biotech start-ups; aligns with BioE3 (Biotechnology for Economy, Environment, Employment) ecosystem under DBT [S5].
Social: NPRD targets vulnerable rare-disease patients, ~70% of whom are children; affordability addressed via ₹50 lakh ceiling at CoEs [S2][S3].
Administrative: Consolidation of 14 DBT autonomous bodies under BRIC to remove silos and pool research infrastructure [S5].
Ethical / Governance: Genetic data raises consent, privacy and data-protection issues (interface with DPDP Act 2023) [S1].

9 Jan 2026 — SAMARTH foundation + iDEA-NA incubator inaugurated at CDFD Hyderabad [S1].
5–6 May 2026 — Union MoHFW inaugurated 2-day National Conference on Rare Diseases, New Delhi [S6].
BRIC operationalised as umbrella body for DBT autonomous institutes including CDFD [S5].

CDFD = Centre for DNA Fingerprinting and Diagnostics, Hyderabad, under DBT (not ICMR) [S4].
BRIC = Biotechnology Research and Innovation Council, umbrella of 14 DBT autonomous institutes [S5].
NPRD approved on 30 March 2021 [S2].
Rare diseases classified into 3 Groups under NPRD 2021 [S3].
Financial assistance ceiling under NPRD: ₹50 lakh per patient [S3].
8 CoEs + 5 Nidan Kendras notified for rare diseases [S3].
iDEA-NA = incubator at BRIC-CDFD, inaugurated Jan 2026 [S1].
Dr Jitendra Singh holds Independent Charge of Ministry of Science & Technology [S1].
Foundation event held at DBT-CDFD Hyderabad, 9 Jan 2026 [S1].
SAMARTH — National Skill Development Centre for biotech at CDFD [S1].

GS-II: Government policies & interventions — Health (Issues relating to development of social sector).
GS-III: Science & Technology — developments and applications in everyday life; indigenisation; biotechnology.
Likely stems: 1. "Examine how India's pivot from infectious-disease control to personalised medicine reflects a maturing public-health agenda. Discuss the role of DBT and BRIC." 2. "Critically evaluate the National Policy for Rare Diseases, 2021 in addressing affordability and access." 3. "Biotech incubators are central to translating publicly funded R&D into health-tech products. Discuss with reference to BIRAC and BRIC-CDFD."

BIRAC — DBT's start-up funding arm; complements iDEA-NA incubator.
Genome India Project — 10,000-genome sequencing; foundation for personalised medicine.
BioE3 Policy 2024 — biomanufacturing policy of DBT.
Ayushman Bharat / PM-JAY — financing dimension for rare-disease care.
DPDP Act 2023 — genetic data privacy implications.
ICMR & NIN Hyderabad — parallel biomedical research ecosystem.
National Medical Devices Policy 2023 — diagnostics manufacturing.
Skill India Mission — context for SAMARTH skill centres.

CDFD is under DBT (Min. of Science & Technology), not under MoHFW/ICMR [S4].
NPRD 2021 is administered by MoHFW, while CDFD/BRIC initiatives are under DBT — two different ministries [S2][S4].
BRIC ≠ BIRAC: BRIC is the umbrella council of DBT institutes; BIRAC is the start-up funding PSU [S5].
NPRD financial assistance is ₹50 lakh per patient — not ₹20 lakh (earlier 2020 draft cap) [S3].
Dr Jitendra Singh holds Independent Charge of S&T, not Cabinet rank for the ministry [S1].

[S1] From infectious diseases to personalised medicine… — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2212942 — (tier 1)
[S2] Union Health Minister approves National Policy for Rare Diseases, 2021 — https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1709369 — (tier 1)
[S3] Steps taken for Treatment of Patients suffering from Rare Diseases — https://pib.gov.in/PressReleasePage.aspx?PRID=1942712 — (tier 1)
[S4] Centre for DNA Fingerprinting and Diagnostics — https://dbtindia.gov.in/autonomousinstitutespsus/centre-dna-fingerprinting-and-diagnostics — (tier 1)
[S5] Department of Biotechnology — iBRIC — https://dbtindia.gov.in/about-us/organization-structure/ibric — (tier 1)
[S6] National Conference on Rare Diseases (5–6 May 2026) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2257977 — (tier 1)